Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-01 Sale |
2023-05-03 7:49 pm |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
80,376 | $2.5759 | $207,041 | 2,753,319 (Indirect Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 7:49 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
106,176 | $2.5964 | $275,678 | 2,971,136 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 7:48 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
455,528 | $2.5759 | $1,173,395 | 15,976,784 (Direct) |
View |
| 2023-05-01 Sale |
2023-05-03 7:46 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
455,536 | $2.5759 | $1,173,415 | 16,887,336 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 6:19 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
413,168 | $2.5572 | $1,056,553 | 16,432,312 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 6:18 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
432,928 | $2.5572 | $1,107,083 | 17,342,872 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 6:17 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
118,712 | $2.5501 | $302,731 | 3,092,312 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 6:15 pm |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
152,000 | $2.5939 | $394,273 | 2,842,023 (Indirect Direct) |
View |
| 2022-12-22 Sale |
2022-12-27 6:50 pm |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
240,000 | $2.6918 | $646,032 | 2,806,895 (Indirect Direct) |
View |
| 2022-12-22 Sale |
2022-12-27 5:38 pm |
Verona Pharma plc | VRNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director |
6,139,864 | $22.15 | $136,000,855 | 34,085,528 (Indirect) |
View |
| 2022-12-22 Sale |
2022-12-27 5:32 pm |
Verona Pharma plc | VRNA | Gupta Rishi Director |
6,139,864 | $22.15 | $136,000,855 | 34,085,528 (Indirect) |
View |
| 2022-12-20 Sale |
2022-12-21 4:06 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
600,000 | $2.116 | $1,269,600 | 17,775,800 (Direct) |
View |
| 2022-12-20 Sale |
2022-12-21 4:05 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
600,000 | $2.1151 | $1,269,060 | 16,845,480 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:06 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
32,904 | $1.6726 | $55,035 | 18,375,800 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:05 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
28,752 | $1.639 | $47,125 | 3,091,024 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:05 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
13,160 | $1.6726 | $22,011 | 17,445,480 (Direct) |
View |
| 2022-08-15 Purchase |
2022-08-17 4:03 pm |
Verona Pharma plc | VRNA | Access Industries Holdings LLC AI Biotechnology LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
4,800,000 | $1.3125 | $6,300,000 | 55,911,648 (Indirect) |
View |
| 2022-08-09 Sale |
2022-08-11 9:46 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
600,000 | $1.75 | $1,050,000 | 15,263,560 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-11 9:45 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
600,000 | $1.75 | $1,050,000 | 14,313,496 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 4:12 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
32,904 | $0.6998 | $23,026 | 15,863,560 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-03 4:11 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
28,752 | $0.7031 | $20,216 | 2,376,040 (Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 4:10 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
13,168 | $0.6998 | $9,215 | 14,913,496 (Direct) |
View |
| 2022-05-03 Sale |
2022-05-05 7:20 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
32,904 | $0.4956 | $16,307 | 16,351,328 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-01 Exercise(A) |
2023-05-11 4:16 pm |
N/A 2029-03-29 |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
8,328 | $0 | 1,987,391 (Direct) |
View |
| 2023-05-01 Exercise(A) |
2023-05-11 4:15 pm |
N/A 2029-03-29 |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
15,000 | $0 | 2,986,136 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:24 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:23 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Ullman Anders Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:23 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:23 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:22 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Edwards Martin Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:20 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Gupta Rishi Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:18 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Sinha Vikas Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:17 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Cunningham Kenneth Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-04-28 Option Award |
2023-04-28 4:16 pm |
N/A 2033-04-27 |
Verona Pharma plc | VRNA | Brady James Aloysius Director |
96,000 | $0 | 96,000 (Direct) |
View |
| 2023-01-20 Exercise |
2023-02-03 6:17 pm |
N/A 2029-03-29 |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
105,000 | $0 | 3,092,312 (Direct) |
View |
| 2023-02-01 Gift |
2023-02-03 6:15 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
152,000 | $0 | 2,842,023 (Direct) |
View |
| 2023-01-20 Exercise |
2023-02-03 6:15 pm |
N/A 2027-04-26 |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
357,600 | $0 | 2,842,023 (Direct) |
View |
| 2021-11-21 Gift |
2022-12-27 6:50 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
530,416 | $0 | 2,806,895 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
454,856 | $1.6 | 18,375,800 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 4:05 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
56,264 | $1.6 | 3,091,024 (Direct) |
View |
| 2022-11-01 Tax Withholding |
2022-11-03 4:05 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
454,856 | $1.6 | 17,445,480 (Direct) |
View |
| 2022-09-26 Option Award |
2022-09-28 4:07 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
800,000 | $0 | 3,176,040 (Direct) |
View |
| 2022-09-26 Option Award |
2022-09-28 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
800,000 | $0 | 3,046,895 (Direct) |
View |
| 2022-09-26 Option Award |
2022-09-28 4:06 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
3,600,000 | $0 | 17,913,496 (Direct) |
View |
| 2022-09-26 Option Award |
2022-09-28 4:05 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
3,600,000 | $0 | 18,863,560 (Direct) |
View |
Ownership |
2022-08-17 4:01 pm |
N/A N/A |
Verona Pharma plc | VRNA | Access Industries Holdings LLC AI Biotechnology LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
0 | $0 | 51,111,648 (Indirect) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 4:12 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
454,864 | $0.6725 | 15,863,560 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 4:11 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
56,432 | $0.6725 | 2,376,040 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 4:10 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
454,856 | $0.6725 | 14,913,496 (Direct) |
View |
| 2022-08-01 Tax Withholding |
2022-08-03 4:10 pm |
N/A N/A |
Verona Pharma plc | VRNA | Poll Claire General Counsel |
79,896 | $0.6725 | 2,246,895 (Direct) |
View |